You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antibody mediated rejection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Subclass of Donor-specific Antibody asRisk Factor of Antibody

Active, not recruiting
  • Antibody-mediated Rejection
    • Montpellier, Hérault, France
      CHU Lapeyronie
    Jan 18, 2023

    Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

    Not yet recruiting
    • Antibody-mediated Rejection
    • Allosensitization
    • New York, New York
      NYU Langone Health
    May 16, 2023

    Antibody-mediated Rejection, Lung Transplant Rejection Trial (Extracorporeal Photopheresis)

    Not yet recruiting
    • Antibody-mediated Rejection
    • Lung Transplant Rejection
    • Extracorporeal Photopheresis
    • (no location specified)
    Oct 30, 2023

    Kidney Transplant Rejection, Antibody-mediated Rejection, Kidney Transplant Failure Trial in Berlin (Kidney allograft biopsy

    Active, not recruiting
    • Kidney Transplant Rejection
    • +2 more
    • Kidney allograft biopsy depending on donor-derived cell-free DNA levels
    • Berlin, Germany
      Charité-Universitätsmedizin
    Jul 22, 2022

    Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

    Recruiting
    • Antibody-mediated Rejection
    • Vienna, Austria
    • +1 more
    Aug 23, 2022

    ABO Blood Type Incompatible Kidney Transplantation, Antibody-mediated Rejection Trial in Seoul (5-gene classification model)

    Active, not recruiting
    • ABO Blood Type Incompatible Kidney Transplantation
    • Antibody-mediated Rejection
    • 5-gene classification model
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Oct 24, 2022

    Antibody-mediated Rejection, Kidney Tranplant Trial in Hangzhou (Daratumumab)

    Not yet recruiting
    • Antibody-mediated Rejection
    • Kidney Tranplant
    • Hangzhou, Zhejiang, China
      79# Qingchun Road
    Jun 21, 2023

    Assess Burden of Disease Among Kidney Transplant Recipients With

    Recruiting
    • Antibody-mediated Rejection in Kidney Transplant
    • Chronic active AMR group
    • Non-Chronic active AMR group
    • Cardiff, United Kingdom
    • +4 more
    Aug 2, 2022

    Transplant Glomerulopathy Trial in Birmingham, Baltimore (Acthar gel)

    Terminated
    Has Results
    • Transplant Glomerulopathy
    • Acthar gel
    • Birmingham, Alabama
    • +1 more
    Oct 3, 2022

    Donor-Derived Cell-Free DNA With Tocilizumab Treatment for

    Active, not recruiting
    • Rejection Chronic Renal
    • Kidney Transplant Rejection
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jul 18, 2022

      ddcfDNA in Kidney Transplant Recipients

      Recruiting
      • Kidney Transplant Rejection
      • AlloSeq cfDNA
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Aug 22, 2023

      Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

      Active, not recruiting
      • Antibody-mediated Rejection
      • +5 more
      • Los Angeles, California
        Norko Ammerman
      Mar 25, 2022

      Antibody-mediated Rejection Trial in Gothenburg, Stockholm, Uppsala (Tocilizumab)

      Recruiting
      • Antibody-mediated Rejection
      • Gothenburg, Vastra Gotaland Regioin, Sweden
      • +2 more
      Feb 16, 2022

      MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart

      Active, not recruiting
      • Transplant Failure
      • +2 more
      • Echocardiogram
      • +3 more
      • Majadahonda, Madrid, Spain
      • +2 more
      Jun 14, 2022

      Antibody-mediated Rejection Trial in Tehran (Bortezomib)

      Recruiting
      • Antibody-mediated Rejection
      • Tehran, Iran, Islamic Republic of
        SBMU
      Jan 27, 2022

      Donor Specific B Cells and Antibody Mediated Rejection

      Terminated
      • Sensitized Kidney Transplant Recipients
        • Madison, Wisconsin
          University of Wisconsin Hospital and Clinics
        Dec 13, 2021

        Kidney Transplantation, Kidney Transplant Rejection Trial in Guangzhou

        Not yet recruiting
        • Kidney Transplantation
        • Kidney Transplant Rejection
          • Guangzhou, Guangdong, China
            The First Affiliated Hospital, Sun Yat-sen University
          Mar 19, 2023

          Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)

          Enrolling by invitation
          • Antibody-mediated Rejection
          • Cardiac Transplant
          • Daratumumab and hyaluronidase-fihj
          • Rochester, Minnesota
            Mayo Clinic Rochester
          Apr 11, 2022

          Antibody-mediated Rejection, NMO Spectrum Disorder, TTP Trial in Iowa City

          Recruiting
          • Antibody-mediated Rejection
          • +3 more
            • Iowa City, Iowa
              DeGowin blood Center
            Oct 31, 2022

            Lung Transplant Recipient, Donor Specific Antibodies, Antibody Mediated Rejection Trial in France (bronchoscopy.)

            Recruiting
            • Lung Transplant Recipient
            • +2 more
            • bronchoscopy.
            • Le Plessis Robinson, France
            • +4 more
            Feb 11, 2022

            Renal Transplant Rejection Trial in London (Fostamatinib)

            Recruiting
            • Renal Transplant Rejection
            • London, United Kingdom
              Imperial College NHS Healthcare Trust
            Oct 1, 2021

            Incidence, Course and Outcome of ABMR in Kidney Transplantation

            Not yet recruiting
            • Antibody-mediated Rejection
            • +2 more
            • Kidney Transplantation
            • +2 more
            • (no location specified)
            Nov 17, 2021

            Decreased Immunologic Activity, Antibody-mediated Rejection Trial in Vienna (Combined apheresis)

            Terminated
            • Decreased Immunologic Activity
            • Antibody-mediated Rejection
            • Combined apheresis
            • Vienna, Austria
              Division of Medicine III, Dpt. of Nephrology and Dialysis, Medic
            Aug 22, 2022

            Transplant Rejection Trial in Worldwide (BIVV020, Intravenous immunoglobulin (IVIg), Rituximab)

            Recruiting
            • Transplant Rejection
            • Westmead, New South Wales, Australia
            • +14 more
            Aug 2, 2022

            Approach on Kidney Transplant Recipients With Antibody-Mediated

            Completed
            • Antibody-mediated Rejection
            • +2 more
              • Istanbul, Turkey
                Istanbul University
              May 16, 2021